stride study semaglutide What were the key findings and safety outcomes of the trial evaluating in adults with type 2 diabetes and Fontaine IIa peripheral artery disease? STRIDE - Semaglutide and walking

Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al

Sig Transduct Target Ther 9 , 6 (2024)

A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lillys blockbuster GLP-1 drug to treat obesity

For some patients, Zepbound can offer a viable alternative to CPAP therapy, particularly those with obesity-related sleep apnea

Sun exposure is the primary risk factor for amelanotic melanoma

Additionally, the subgroup policies will continue the voluntary subgroup participation option for multispecialty group practices that qualify as small practices